HOUSTON, Oct. 28, 2025 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY) (“Sysco” or the “company”) today announced financial results for its 13-week first fiscal quarter ended September 27, 2025. Key financial results for the first quarter of fiscal year 2026 include the following (comparisons are to the same period in fiscal year 2025):Sales increased 3.2%; U.S. Foodservice volume increased 0.1%; Gross profit increased 3.9% to $3.9 billion; Operating income decreased 1.0% to $800 million, and adjusted operating income increased 2.9% to $898 million1; Net earnings decreased 2.9% to $476 million, and adjusted net earnings increased 2.0% to $551 million1; EBITDA decreased 3.1% to $1.0 billion2, and adjusted EBITDA increased 0.1% to $1.1 billion1,2; and EPS3 remained flat at $0.99, and adjusted EPS1 increased 5.5% to $1.15.“We...

Third Quarter Highlights Highlights for the third quarter of 2025 include:Increase in net interest income of $0.7 million (or 1.7%) over the second quarter of 2025; Increase in tangible common equity per share of common stock of $1.06 (or 20.0% annualized) from June 30, 2025; Net growth in total deposits, less brokered time deposits of $148.2 million (or 13.0% annualized) from June 30, 2025; Net growth in loans of $33.9 million (or 3.2% annualized) from June 30, 2025; and The payment of a 26 cent per share dividend on common stock on August 15, 2025.GRAND RAPIDS, Mich., Oct. 28, 2025 (GLOBE NEWSWIRE) — Independent Bank Corporation (NASDAQ: IBCP) reported third quarter 2025 net income of $17.5 million, or $0.84 per diluted share, versus net income of $13.8 million, or $0.65 per diluted share, in the prior-year period. William...

Revenue of $189 million, year-over-year increase of 22% as reported and 18% organic with double-digit reported growth across all franchises Orders increased sequentially and greater than 20% year-over-year Increasing revenue guidance to a range of $729 to $737 million, which represents 14% -15.5% year-over-year non-COVID organic growthWALTHAM, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its third quarter of 2025, covering the three- and nine- month periods ended September 30, 2025. Provided in this press release are financial performance highlights, updates to our guidance for the full year 2025 and access information for today’s webcast and conference call. Olivier Loeillot, President...

Shelton, CT, Oct. 28, 2025 (GLOBE NEWSWIRE) — HUBBELL REPORTS THIRD QUARTER 2025 RESULTS 3Q diluted EPS of $4.77; adjusted diluted EPS of $5.17 3Q net sales +4% (organic +3%) 3Q operating margin 22.0%; adjusted operating margin 23.9% Raising 2025 diluted EPS outlook to $16.55-$16.75; adj. diluted EPS of $18.10-$18.30Hubbell Incorporated (NYSE: HUBB) today reported operating results for the third quarter ended September 30, 2025. “Hubbell delivered double digit adjusted earnings per diluted share growth in the third quarter, driven by strong organic growth in Electrical Solutions and Grid Infrastructure products within our Utility Solutions segment, as well as a lower year-over-year tax rate” said Gerben Bakker, Chairman, President and CEO. Mr. Bakker continued, “In our Utility Solutions segment, Grid Infrastructure achieved...

– ARCALYST® (rilonacept) Q3 2025 net product revenue of $180.9 million, representing 61% year-over-year growth –– ARCALYST 2025 expected net product revenue raised to $670 – $675 million –– KPL-387 granted Orphan Drug Designation for the treatment of pericarditis – – Cash balance increased by $44.3 million in Q3 2025 to $352.1 million – – Conference call and webcast scheduled for 8:30 am ET today – LONDON, Oct. 28, 2025 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications, today reported third quarter 2025 financial results and recent portfolio execution. “Year to date, ARCALYST revenue has continued to grow, with the expanding adoption of IL-1α...

Continued Strong Orders and Revenue Growth Headline Multiple Performance Records Reaffirms 2025 Full Year Outlook and Introduces 2026 Outlook ADDISON, Texas, Oct. 28, 2025 (GLOBE NEWSWIRE) — CECO Environmental Corp. (Nasdaq: CECO) (“CECO” or the “Company”), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment, and industrial equipment, today reported its financial results for the third quarter of 2025. Third Quarter Summary(1)Orders of $232.9 million, up 44 percent Backlog of $719.6 million, up 64 percent Revenue of $197.6 million, up 46 percent Gross profit margin of 32.7 percent; Gross profit of $64.6 million, up 43 percent Net income of $1.5 million; non-GAAP net income of $9.3 million GAAP EPS (diluted) of $0.04; non-GAAP EPS (diluted) of...

Third quarter 2025 revenues increased 1% to $3.75 billion versus third quarter 2024 Dupixent® global net sales (recorded by Sanofi) increased 27% to $4.86 billion EYLEA HD® U.S. net sales increased 10% to $431 million; total EYLEA HD and EYLEA® U.S. net sales decreased 28% to $1.11 billion GAAP EPS of $13.62 and non-GAAP EPS(a) of $11.83; third quarter 2025 includes unfavorable $0.68 impact from acquired IPR&D charge FDA approved Libtayo® as the first and only immunotherapy for high-risk adjuvant cutaneous squamous cell carcinoma (CSCC); EMA’s CHMP adopted positive opinion Positive Phase 3 results reported from trials in generalized myasthenia gravis, fibrodysplasia ossificans progressiva (FOP), and cat and birch allergies; updated positive data reported from pivotal trial in children with profound genetic hearing lossTARRYTOWN,...

ORION CORPORATION INTERIM REPORT 1–9/2025 28 OCTOBER 2025 at 12:00 EET Orion Group Interim Report January–September 2025 July–September 2025 HighlightsNet sales totalled EUR 423.2 (July–September 2024: 471.3) million Operating profit was EUR 121.0 (202.0) million Net sales and operating profit of the comparison period include EUR 130 million of major milestone payments Basic earnings per share were EUR 0.68 (1.14) Cash flow from operating activities per share was EUR 0.55 (0.48) The outlook for 2025 has been specified: Net sales are estimated to be EUR 1,640 million to EUR 1,720 million. Operating profit is estimated to be EUR 410 million to EUR 490 million. Previously net sales were estimated to be EUR 1,630 million to EUR 1,730 million and operating profit was estimated to be EUR 400 million to EUR 500 million.January–September...

Strong Demand Drives 20 Percent Calculated Billings Growth Year Over Year TEL AVIV, Israel, Oct. 28, 2025 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), today announced its financial results for the quarter ended September 30th, 2025. Third Quarter 2025 Financial Highlights:Calculated Billings*: $672 million, a 20 percent increase year over year Total Revenues: $678 million, a 7 percent increase year over year Security Subscriptions Revenues: $305 million, a 10 percent increase year over year GAAP Operating Income: $199 million, representing 29 percent of total revenues Non-GAAP Operating Income: $282 million, representing 42 percent of total revenues GAAP EPS**: $3.28, a 79 percent increase year over year Non-GAAP EPS**: $3.94, a 75 percent increase year over year“Check Point delivered strong third...

PHILADELPHIA, Oct. 28, 2025 (GLOBE NEWSWIRE) — Axalta Coating Systems Ltd. (NYSE:AXTA) (“Axalta”), a leading global coatings company, announced its financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights:Third quarter net sales of approximately $1.3 billion Net income of $110 million with a net income margin of 8.5%, an increase of 80 basis points year over year Record quarter for Adjusted EBITDA of $294 million Adjusted EBITDA margin expanded 70 basis points year over year to 22.8% Diluted EPS increased 11% to $0.51 Record quarter for Adjusted Diluted EPS of $0.67, an increase of 6% Executed $100 million in share repurchases“We executed another strong quarter delivering record Adjusted EBITDA and Adjusted Diluted EPS. Our results reflect our focus on operational excellence while the...